Correction: Inhibition of NAPDH Oxidase 2 (NOX2) prevents oxidative stress and mitochondrial abnormalities caused by saturated fat in cardiomyocytes (PLoS ONE (2016) 11:1 (e0145750) DOI: 10.1371/journal.pone.0145750);Inhibition of napdh oxidase 2 (nox2) prevents oxidative stress and mitochondrial abnormalities caused by saturated fat in cardiomyocytes

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Joseph, Leroy C ^a   Barca, Emanuele ^a   Subramanyam, Prakash ^b   Komrowski, Michael ^a   Pajvani, Utpal ^a   Colecraft, Henry M ^b   Hirano, Michio ^a   Morrow, John P ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALMITIC ACID; PALMITOLEIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SATURATED FATTY ACID; ANTIMYCIN A1; ANTIOXIDANT; CALCIUM; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN; PALMITIC ACID DERIVATIVE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CELL ISOLATION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; ENZYME INHIBITION; GENE; GENE DELETION; HEART MUSCLE CELL; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; NOX2 GENE; OXIDATIVE STRESS; SARCOPLASMIC RETICULUM; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ELECTRON TRANSPORT; GENETICS; HEART VENTRICLE; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRION; MUSCLE CELL; OXYGEN CONSUMPTION; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIMYCIN A; ANTIOXIDANTS; APOPTOSIS; CALCIUM; CELL LINE; ELECTRON TRANSPORT; GENE DELETION; HEART VENTRICLES; HOMEOSTASIS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; MUSCLE CELLS; MYOCYTES, CARDIAC; NADPH OXIDASE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PALMITATES; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

EID: 84954523187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0174525     Document Type: Erratum

References (57)

1. Szczepaniak LS, Victor RG, Orci L, Unger RH. Forgotten but not gone: The rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res. 2007; 101:759-67. PMID: 17932333.
2. Morrow JP, Katchman A, Son NH, Trent CM, Khan R, Shiomi T, et al. Mice With Cardiac Overexpression of Peroxisome Proliferator-Activated Receptor gamma Have Impaired Repolarization and Spontaneous Fatal Ventricular Arrhythmias. Circulation. 2011; 124:2812-21. doi:10.1161/CIRCULATIONAHA.111.056309 PMID: 22124376.
3. Son NH, Park TS, Yamashita H, Yokoyama M, Huggins LA, Okajima K, et al. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest. 2007; 117:2791-801. PMID: 17823655.
4. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004; 18:1692-700. PMID: 15522914.
5. Selvin E, Lazo M, Chen Y, Shen L, Rubin J, McEvoy JW, et al. Diabetes, Pre-Diabetes and Incidence of Subclinical Myocardial Damage. Circulation. 2014.
6. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. The New England journal of medicine. 2002; 347:305-13. PMID: 12151467.
7. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol. 1974; 34:29-34. PMID: 4835750.
8. Wang TJ, Parise H, Levy D, D'Agostino RB Sr., Wolf PA, Vasan RS, et al. Obesity and the risk of newonset atrial fibrillation. Jama. 2004; 292:2471-7. PMID: 15562125.
9. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: The CHARGE-AF consortium. Journal of the American Heart Association. 2013; 2:e000102. doi:10.1161/JAHA.112.000102 PMID: 23537808.
10. Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003; 107:2096-101. PMID: 12695299.
11. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation. 1999; 99:1978-83. PMID: 10209001.
12. Filippi A, Sessa E Jr., Mazzaglia G, Pecchioli S Jr., Capocchi R Jr., Caprari F, et al. Out of hospital sudden cardiac death in Italy: A population-based case-control study. J Cardiovasc Med (Hagerstown). 2008; 9:595-600.
13. Hookana E, Junttila MJ, Puurunen VP, Tikkanen JT, Kaikkonen KS, Kortelainen ML, et al. Causes of nonischemic sudden cardiac death in the current era. Heart Rhythm. 2011; 8:1570-5. doi:10.1016/j.hrthm.2011.06.031 PMID: 21740887.
14. Jouven X, Charles MA, Desnos M, Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation. 2001; 104:756-61. PMID: 11502698.
15. Oliver MF, Kurien VA, Greenwood TW. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet. 1968; 1:710-4. PMID: 4170959.
16. Chiuve SE, Rimm EB, Sandhu RK, Bernstein AM, Rexrode KM, Manson JE, et al. Dietary fat quality and risk of sudden cardiac death in women. The American journal of clinical nutrition. 2012; 96:498-507. doi:10.3945/ajcn.112.040287 PMID: 22854398.
17. Lemaitre RN, King IB, Sotoodehnia N, Knopp RH, Mozaffarian D, McKnight B, et al. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism. 2010; 59:1029-34. doi:10.1016/j.metabol.2009.10.026 PMID: 20045147.
18. Luo M, Guan X, Luczak ED, Lang D, Kutschke W, Gao Z, et al. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J Clin Invest. 2013; 123:1262-74. doi:10.1172/JCI65268PMID: 23426181.
19. Yang KC, Dudley SC Jr. Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle. Circulation. 2013; 128:1724-6. doi:10.1161/circulationaha.113.005837 PMID: 24030497.
20. Steinberg SF. Oxidative stress and sarcomeric proteins. Circ Res. 2013; 112:393-405. doi:10.1161/CIRCRESAHA.111.300496 PMID: 23329794.
21. Santos CX, Anilkumar N, Zhang M, Brewer AC, Shah AM. Redox signaling in cardiac myocytes. Free Radic Biol Med. 2011; 50:777-93. doi:10.1016/j.freeradbiomed.2011.01.003 PMID: 21236334.
22. Madamanchi NR, Runge MS. Redox signaling in cardiovascular health and disease. Free Radic Biol Med. 2013; 61C:473-501.
23. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 2009; 119:573-81. doi:10.1172/JCI37048 PMID: 19188683.
24. Cole MA, Murray AJ, Cochlin LE, Heather LC, McAleese S, Knight NS, et al. A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res Cardiol. 2011; 106:447-57. doi:10.1007/s00395-011-0156-1 PMID: 21318295.
25. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem. 2002; 277:44784-90. PMID: 12237311.
26. Schonfeld P, Wojtczak L. Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. Biochim Biophys Acta. 2007; 1767:1032-40. PMID: 17588527.
27. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008; 7:45-56. doi:10.1016/j.cmet.2007.10.013 PMID: 18177724.
28. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids. 2010; 45:893-905. doi:10.1007/s11745-010-3393-4 PMID: 20354806.
29. Watt MJ, Hoy AJ, Muoio DM, Coleman RA. Distinct roles of specific fatty acids in cellular processes: implications for interpreting and reporting experiments. Am J Physiol Endocrinol Metab. 2012; 302: E1-E3. doi:10.1152/ajpendo.00418.2011 PMID: 22180647.
30. Eruslanov E, Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol. 2010; 594:57-72. doi:10.1007/978-1-60761-411-1-4 PMID: 20072909.
31. Bowser DN, Minamikawa T, Nagley P, Williams DA. Role of mitochondria in calcium regulation of spontaneously contracting cardiac muscle cells. Biophysical journal. 1998; 75:2004-14. PMID: 9746542.
32. Bendall JK, Cave AC, Heymes C, Gall N, Shah AM. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation. 2002; 105:293-6. PMID: 11804982.
33. DiMauro S, Servidei S, Zeviani M, DiRocco M, DeVivo DC, DiDonato S, et al. Cytochrome c oxidase deficiency in Leigh syndrome. Annals of neurology. 1987; 22:498-506. PMID: 2829705.
34. Birch-Machin MA, Briggs HL, Saborido AA, Bindoff LA, Turnbull DM. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochemical medicine and metabolic biology. 1994; 51:35-42. PMID: 8192914.
35. Brynes AE, Mark Edwards C, Ghatei MA, Dornhorst A, Morgan LM, Bloom SR, et al. A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. The British journal of nutrition. 2003; 89:207-18. PMID: 12575905.
36. Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011; 435:297-312. doi:10.1042/BJ20110162 PMID: 21726199.
37. Liu Q, Chen X, Macdonnell SM, Kranias EG, Lorenz JN, Leitges M, et al. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ Res. 2009; 105:194-200. doi:10.1161/CIRCRESAHA.109.195313 PMID: 19556521.
38. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med. 2011; 51:1289-301. doi:10.1016/j.freeradbiomed.2011.06.033 PMID: 21777669.
39. Biary N, Xie C, Kauffman J, Akar FG. Biophysical properties and functional consequences of reactive oxygen species (ROS)-induced ROS release in intact myocardium. J Physiol. 2011; 589:5167-79. doi:10.1113/jphysiol.2011.214239 PMID: 21825030.
40. Fessenden JD, Feng W, Pessah IN, Allen PD. Amino acid residues Gln4020 and Lys4021 of the ryanodine receptor type 1 are required for activation by 4-chloro-m-cresol. J Biol Chem. 2006; 281:21022-31. PMID: 16737973.
41. Carlsson C, Borg LA, Welsh N. Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology. 1999; 140:3422-8. PMID: 10433196.
42. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation. 2005; 112:2686-95. PMID: 16246967.
43. Wojtczak L, Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta. 1993; 1183:41-57. PMID: 8399375.
44. Dyntar D, Eppenberger-Eberhardt M, Maedler K, Pruschy M, Eppenberger HM, Spinas GA, et al. Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes. 2001; 50:2105-13. PMID: 11522678.
45. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr., Ory DS, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A. 2003; 100:3077-82. PMID: 12629214.
46. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. The Journal of experimental medicine. 2000; 192:1001-14. PMID: 11015441.
47. Sirker A, Zhang M, Shah AM. NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol. 2011; 106:735-47. doi:10.1007/s00395-011-0190-z PMID: 21598086.
48. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol. 2003; 41:2164-71. PMID: 12821241.
49. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res. 2005; 97: 629-36. PMID: 16123335.
50. Dudley SC Jr., Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: Role of the NADPH and xanthine oxidases. Circulation. 2005; 112:1266-73. PMID: 16129811.
51. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med. 2004; 10:248-54. PMID: 14966518.
52. Prosser BL, Ward CW, Lederer WJ. X-ROS signaling: Rapid mechano-chemo transduction in heart. Science. 2011; 333:1440-5. doi:10.1126/science.1202768 PMID: 21903813.
53. Hayashi T, Martone ME, Yu Z, Thor A, Doi M, Holst MJ, et al. Three-dimensional electronmicroscopy reveals new details ofmembrane systems for Ca2+ signaling in the heart. J Cell Sci. 2009; 122:1005-13. doi:10.1242/jcs.028175 PMID: 19295127.
54. Harling L, Rasoli S, Vecht JA, Ashrafian H, Kourliouros A, Athanasiou T. Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials. Heart. 2011; 97:1636-42. doi:10.1136/heartjnl-2011-300245 PMID: 21865202.
55. Rodrigo R, Korantzopoulos P, Cereceda M, Asenjo R, Zamorano J, Villalabeitia E, et al. A Randomized Controlled Trial to Prevent Postoperative Atrial Fibrillation by Antioxidant Reinforcement. J Am Coll Cardiol. 2013.
56. Rodrigo R, Korantzopoulos P, Cereceda M, Asenjo R, Zamorano J, Villalabeitia E, et al. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. J Am Coll Cardiol. 2013; 62:1457-65. doi:10.1016/j.jacc.2013.07.014 PMID: 23916928.
57. Marx SO, Marks AR. Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases. J Mol Cell Cardiol. 2013; 58:225-31. doi:10.1016/j.yjmcc.2013.03.005 PMID: 23507255